Literature DB >> 27844223

Untreated head and neck cancer in Korea: a national cohort study.

Hyo Geun Choi1, Bumjung Park1, Soon-Hyun Ahn2.   

Abstract

Few studies have analyzed the survival of patients with untreated head and neck cancer. The objective of this study is to assess the survival rates of untreated head and neck cancer patients and to determine why the patients were not treated. Using data from a national patient sample cohort (1,025,340 cases) from the Korean Health Insurance Review and Assessment Service, 605 patients with diagnoses of head and neck cancer (lip and oral cavity, oropharynx, hypopharynx, and laryngeal cancer) between 2003 and 2013 were evaluated. Cox proportional hazards modeling and multiple logistic regression analysis were performed. Of the considered cases of head and neck cancer, 32.2% were untreated. The median survival rate of untreated groups was 9 months. The untreated group showed poorer survival than the treatment groups. Old age [adjusted odds ratio (AOR) = 1.37, 95% confidence internal (CI) 1.25-1.49, P < 0.001] and low income (AOR = 0.94, 95% CI 0.89-1.00, P = 0.028) were related to not receiving treatment. Many head and neck cancers go untreated. Clinicians should focus on untreated patients and seek to understand the reasons for their lack of treatment.

Entities:  

Keywords:  Head and neck neoplasms; Mortality; Survival; Therapy; Treatment refusal

Mesh:

Year:  2016        PMID: 27844223     DOI: 10.1007/s00405-016-4392-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  11 in total

1.  Natural history of untreated head and neck cancer.

Authors:  L P Kowalski; A L Carvalho
Journal:  Eur J Cancer       Date:  2000-05       Impact factor: 9.162

2.  The natural history of untreated squamous cell carcinoma of the head and neck: how we do it.

Authors:  J-P Jeannon; E Ofu; A Balfour; J Bowman; R Simo
Journal:  Clin Otolaryngol       Date:  2011-08       Impact factor: 2.597

Review 3.  Epidemiology of head and neck cancer.

Authors:  Eleni M Rettig; Gypsyamber D'Souza
Journal:  Surg Oncol Clin N Am       Date:  2015-04-09       Impact factor: 3.495

4.  Prevalence and characteristics of patients with metastatic cancer who receive no anticancer therapy.

Authors:  Alexander C Small; Che-Kai Tsao; Erin L Moshier; Benjamin A Gartrell; Juan P Wisnivesky; James H Godbold; Cardinale B Smith; Guru Sonpavde; William K Oh; Matthew D Galsky
Journal:  Cancer       Date:  2012-06-15       Impact factor: 6.860

Review 5.  Update on Head and Neck Cancer: Current Knowledge on Epidemiology, Risk Factors, Molecular Features and Novel Therapies.

Authors:  Francesca Pezzuto; Luigi Buonaguro; Francesco Caponigro; Franco Ionna; Noemy Starita; Clorinda Annunziata; Franco M Buonaguro; Maria Lina Tornesello
Journal:  Oncology       Date:  2015-05-08       Impact factor: 2.935

6.  The untreated patient with squamous carcinoma of the head and neck.

Authors:  A S Jones
Journal:  Am J Clin Oncol       Date:  1995-08       Impact factor: 2.339

7.  Survival outcomes in elderly patients with untreated upper aerodigestive tract cancer.

Authors:  Brian B Hughley; Steven M Sperry; Timothy A Thomsen; Mary E Charlton; Nitin A Pagedar
Journal:  Head Neck       Date:  2016-08-10       Impact factor: 3.147

8.  African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patients.

Authors:  Manuel A Molina; Michael C Cheung; Eduardo A Perez; Margaret M Byrne; Dido Franceschi; Frederick L Moffat; Alan S Livingstone; W Jarrard Goodwin; Juan C Gutierrez; Leonidas G Koniaris
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  Socioeconomic and Other Demographic Disparities Predicting Survival among Head and Neck Cancer Patients.

Authors:  Seung Hee Choi; Jeffrey E Terrell; Karen E Fowler; Scott A McLean; Tamer Ghanem; Gregory T Wolf; Carol R Bradford; Jeremy Taylor; Sonia A Duffy
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

View more
  4 in total

1.  Factors impacting on discordance with treatment plan in head and neck cancer patients: a retrospective, population-based cohort study.

Authors:  Ya-Lan Chang; Shu-Chu Lee; Chun-Ta Liao; Chao-Hui Wang; Yu-Fen Lin; Shu-Ching Chen
Journal:  Support Care Cancer       Date:  2019-06-08       Impact factor: 3.603

Review 2.  Head and neck cancer patients declining curative treatment: a case series and literature review.

Authors:  Axel Sahovaler; Tommaso Gualtieri; David Palma; Kevin Fung; S Danielle MacNeil; John Yoo; Anthony Nichols
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-02       Impact factor: 2.124

3.  The impact of patient preference in the treatment algorithm for recurrent/metastatic head and neck squamous cell carcinoma.

Authors:  Viola Salvestrini; Carlotta Becherini; Isacco Desideri; Luisa Caprara; Matteo Mariotti; Marco Banini; Nicola Pierossi; Vieri Scotti; Lorenzo Livi; Pierluigi Bonomo
Journal:  Radiol Med       Date:  2022-06-25       Impact factor: 6.313

4.  Untreated head and neck cancer: Natural history and associated factors.

Authors:  Paul Zolkind; Jake J Lee; Ryan S Jackson; Patrik Pipkorn; Sean T Massa
Journal:  Head Neck       Date:  2020-09-11       Impact factor: 3.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.